Article Details

Lepodisiran's Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of ... - Consult QD

Retrieved on: 2025-04-01 13:38:39

Tags for this article:

Click the tags to see associated articles and topics

Lepodisiran's Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of ... - Consult QD. View article details on hiswai:

Excerpt

... atherosclerotic cardiovascular disease and aortic stenosis. Approximately 20% to 25% of the population has elevated blood levels of Lp(a) — i.e. ...

Article found on: consultqd.clevelandclinic.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up